Adaptyx
Founded 2022 · 19 employees on LinkedIn · 6 known investors
Find your way into Adaptyx
2,633 people in our graph share verified history with the Adaptyx team — schools, employers, funds. One of them is your warm intro.
Javier Solterounlockedknows Alex Yoshikawa · together at Carnegie Mellon University (overlapped)
×10knows the team · via Stanford University
knows the team · via StartX
Adaptyx develops a minimally-invasive wearable dermal patch that continuously measures biomarkers in interstitial fluid using an array of programmable molecular switches. The continuous data feeds algorithms intended to help clinicians make timelier decisions and reduce avoidable complications and hospital readmissions, replacing traditional lab draws and repeat clinic visits.
Founders & leadership
Adaptyx was founded in 2022 by Vijit Sabnis, Alex Yoshikawa, Pawan Kapur, H. Tom Soh, and Joseph M. DeSimone.
VS
AY
Alex YoshikawainCo-Founder & Chief Science OfficerAlex Yoshikawa is Co-Founder and Chief Science Officer of Adaptyx Biosciences, bringing over a decade of research experience in biosensing and biomolecular engineering. He leads the development of the company's wearable dermal patch technology for continuous molecular monitoring.
PK
Pawan KapurinCo-Founder & Chief Technology OfficerHe has built multiple startups and leads R&D and product development; his background spans semiconductor devices, medical devices, wearables, and process technology, with approximately 90 patent filings and 65 publications.
HT
H. Tom SohCo-Founder & Scientific Advisor
JM
Joseph M. DeSimoneCo-Founder & Scientific Advisor
DG
Daniel GrossmaninChief Medical & Business OfficerHe has practiced medicine in both U.S. and international low-resource healthcare settings and has developed networks across multiple healthcare environments.
Investors · 6
.jpeg){kind=logo}
Competitors · 3
by search overlapBioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
AltrixBio10 shared keywordsAltrixBio develops AJN003, a non-systemic, once-daily oral therapy for type 2 diabetes and related metabolic conditions that transiently coats the stomach and upper intestine to shift nutrient sensing and trigger a metabolic reset similar to bariatric surgery. The drug targets glycemic control and weight loss and is positioned as a complement or alternative to incretin-based (GLP-1) treatments, with potential applications in broader cardiometabolic diseases.
Fortis Life Sciences9 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Companies competing with Adaptyx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Shark Tank featured startup NapTapGo raises Rs 8 crore fundingzeebiz.com · Jul 2026Frequently asked questions
- What does Adaptyx do?
- Adaptyx develops a minimally-invasive wearable dermal patch that continuously measures biomarkers in interstitial fluid using an array of programmable molecular switches. The continuous data feeds algorithms intended to help clinicians make timelier decisions and reduce avoidable complications and hospital readmissions, replacing traditional lab draws and repeat clinic visits.
- Who founded Adaptyx?
- Adaptyx was founded by Vijit Sabnis, Alex Yoshikawa, Pawan Kapur, H. Tom Soh, Joseph M. DeSimone in 2022.
- Who are Adaptyx's investors?
- Adaptyx's investors include AIN Ventures, Humba Ventures, Overwater Ventures Llc, Chemistry, Craft Ventures, Pace Capital.